(Q43040809)

English

Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C.

scientific article published in September 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

peginterferon alfa-2a

1 reference

based on heuristic

inferred from title

9

object named as

Stefan Zeuzem

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

4

object named as

Lindsay McNair

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Nicole Forestier

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hendrik W Reesink

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Christine J Weegink

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Tara L Kieffer

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hui-May Chu

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Susan Purdy

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Peter L M Jansen

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

0 references

publication date

1 September 2007

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

640-648

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21774

7 January 2021

based on heuristic

inferred from DOI database lookup

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21774

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21774

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a phase Ib, placebo-controlled, randomized study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21774

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21774

7 January 2021

based on heuristic

inferred from DOI database lookup

Peginterferon alfa-2a in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21774

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of a hepatitis C virus NS3-NS4A protease inhibitor and alpha interferon synergistically inhibits viral RNA replication and facilitates viral RNA clearance in replicon cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21774

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21774

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21774

7 January 2021

based on heuristic

inferred from DOI database lookup

Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21774

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.21774

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43040809&oldid=2162373144"